(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.
The three biggest winners today are Sorrento Therapeutics, DraftKings, and HubSpot.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | Sorrento Therapeutics (SRNE) | 0.31 | 20.2% | 2023-02-20 10:00:56 |
| 2 | DraftKings (DKNG) | 20.54 | 15.33% | 2023-02-20 10:03:14 |
| 3 | HubSpot (HUBS) | 404.65 | 11.8% | 2023-02-20 10:14:53 |
| 4 | Emergent Biosolutions (EBS) | 16.29 | 10.22% | 2023-02-20 05:07:09 |
| 5 | Full House Resorts (FLL) | 10.07 | 8.05% | 2023-02-20 10:11:54 |
| 6 | Deere & Company (DE) | 433.31 | 7.53% | 2023-02-20 10:22:58 |
| 7 | Xenetic Biosciences (XBIO) | 0.58 | 7.28% | 2023-02-20 09:06:48 |
| 8 | Employers Holdings (EIG) | 45.99 | 6.9% | 2023-02-20 07:11:08 |
| 9 | Marathon (MARA) | 7.70 | 6.8% | 2023-02-20 10:13:40 |
| 10 | Virgin Galactic (SPCE) | 6.37 | 6.52% | 2023-02-20 10:22:34 |
The three biggest losers today are XP, Dropbox, and Cross Timbers Royalty Trust.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | XP (XP) | 12.91 | -18.75% | 2023-02-20 04:20:12 |
| 2 | Dropbox (DBX) | 21.22 | -11.44% | 2023-02-20 10:08:25 |
| 3 | Cross Timbers Royalty Trust (CRT) | 26.69 | -10.01% | 2023-02-19 22:17:08 |
| 4 | Albemarle (ALB) | 258.01 | -9.67% | 2023-02-20 10:06:40 |
| 5 | Antero Resources (AR) | 25.23 | -8.39% | 2023-02-20 10:09:58 |
| 6 | Qwest Corporation 6.875% Notes due 2054 (CTV) | 1.99 | -8.29% | 2023-02-19 23:08:08 |
| 7 | Comstock Resources (CRK) | 12.06 | -7.94% | 2023-02-19 21:15:09 |
| 8 | Sabre Corporation (SABR) | 5.32 | -7.8% | 2023-02-20 10:00:26 |
| 9 | SmileDirectClub (SDC) | 0.59 | -7.19% | 2023-02-20 09:05:53 |
| 10 | Vaalco Energy (EGY) | 4.39 | -6.79% | 2023-02-20 07:09:08 |
Winners today
1. Sorrento Therapeutics (SRNE) – 20.2%
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library and targeted delivery modalities, which include chimeric antigen receptor T-cell therapy (CAR-T), dimeric antigen receptor T-cell therapy, and antibody drug conjugate, as well as bispecific antibody approach; and Sofusa, a drug delivery technology that deliver biologic directly into the lymphatic system. Its clinical programs in development include anti-CD38 CAR-T therapy for the treatment of multiple myeloma, as well as for amyloidosis and graft versus host disease. The company develops resiniferatoxin, a non-opioid-based TRPV1 agonist neurotoxin for late stage cancer and osteoarthritis knee pain treatment; and ZTlido, a lidocaine delivery system for the treatment of postherpetic neuralgia. It engages in the development of SEMDEXA, an injectable viscous gel formulation, which is Phase III trial for the treatment of sciatica, a pathology of low back pain; SP-103, an investigational non-aqueous lidocaine topical system undergoing clinical development in chronic low back pain condition; and SP-104, a novel low-dose delayed-release naltrexone hydrochloride formulation for the treatment of fibromyalgia. It has collaboration with SmartPharm Therapeutics Inc. to develop gene-encoded antibody vaccine to protect against COVID-19; Celularity, Inc. for initiating Phase I/II clinical study, including up to 94 patients with COVID-19; Mount Sinai Health System to develop COVI-SHIELD, an antibody therapy targeting SARS-CoV-2 infection; and Mayo Clinic for Phase Ib pilot study using sofusa lymphatic drug delivery technology to deliver Ipilimumab in patient with melanoma. The company was founded in 2006 and is based in San Diego, California.
NASDAQ ended the session with Sorrento Therapeutics jumping 20.2% to $0.31 on Monday, after two successive sessions in a row of gains. NASDAQ fell 0.58% to $11,787.27, after two sequential sessions in a row of losses, on what was a somewhat down trend trading session today.
Earnings Per Share
As for profitability, Sorrento Therapeutics has a trailing twelve months EPS of $-1.3.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -378.92%.
Moving Average
Sorrento Therapeutics’s value is way below its 50-day moving average of $0.94 and way under its 200-day moving average of $1.63.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 50% and 66%, respectively.
Volume
Today’s last reported volume for Sorrento Therapeutics is 180998000 which is 522.54% above its average volume of 29073600.
More news about Sorrento Therapeutics.
2. DraftKings (DKNG) – 15.33%
DraftKings Inc. operates a digital sports entertainment and gaming company. It offers multi-channel sports betting and gaming technologies, powering sports and gaming entertainment for operators in 17 countries. The company operates iGaming through its DraftKings brand in 5 states, as well as operates Golden Nugget Online Gaming, an iGaming product and gaming brand in 3 states. Its Sportsbook is live with mobile and/or retail betting operations in the United States pursuant to regulations in 18 states. The company's daily fantasy sports product is available in 6 countries internationally with 15 distinct sports categories. In addition, it offers DraftKings Marketplace, a digital collectibles ecosystem designed for mainstream accessibility that offers curated NFT drops and supports secondary-market transactions, as well as owns Vegas Sports Information Network (VSiN), a multi-platform broadcast and content company. DraftKings Inc. was founded in 2011 and is headquartered in Boston, Massachusetts.
NASDAQ ended the session with DraftKings rising 15.33% to $20.54 on Monday while NASDAQ dropped 0.58% to $11,787.27.
Earnings Per Share
As for profitability, DraftKings has a trailing twelve months EPS of $-3.62.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -89.63%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, DraftKings’s stock is considered to be oversold (<=20).
More news about DraftKings.
3. HubSpot (HUBS) – 11.8%
HubSpot, Inc. provides a cloud-based customer relationship management (CRM) platform for businesses in the Americas, Europe, and the Asia Pacific. The company's CRM platform includes marketing, sales, service, and content management systems, as well as integrated applications, such as search engine optimization, blogging, website content management, messaging, chatbots, social media, marketing automation, email, predictive lead scoring, sales productivity, knowledge base, commerce, conversation routing, video hosting, ticketing and helpdesk tools, customer NPS surveys, analytics, and reporting. It also offers professional services to educate and train customers on how to leverage its CRM platform, as well as phone and/or email and chat-based support services. The company serves mid-market business-to-business companies. HubSpot, Inc. was incorporated in 2005 and is headquartered in Cambridge, Massachusetts.
NYSE ended the session with HubSpot rising 11.8% to $404.65 on Monday while NYSE fell 0.21% to $15,840.16.
Earnings Per Share
As for profitability, HubSpot has a trailing twelve months EPS of $-1.9.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -13.05%.
Volatility
HubSpot’s last week, last month’s, and last quarter’s current intraday variation average was 3.51%, 1.03%, and 2.92%.
HubSpot’s highest amplitude of average volatility was 4.28% (last week), 3.14% (last month), and 2.92% (last quarter).
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 41.4% and 9.3%, respectively.
More news about HubSpot.
4. Emergent Biosolutions (EBS) – 10.22%
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of specialty products for civilian and military populations that address accidental, deliberate, and naturally occurring public health threats (PHTs). The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emerging infectious diseases; travel health; and emerging health crises and acute/emergency care. It offers BioThrax, an anthrax vaccine; ACAM2000, a smallpox vaccine; Vaxchora, a cholera vaccine; and Vivotif, a typhoid vaccine. The company also provides NARCAN for the emergency treatment of known or suspected opioid overdose; Reactive Skin Decontamination Lotion Kit, a medical device to remove or neutralize chemical warfare agents from the skin; and Trobigard a combination drug-device auto injector product candidate. In addition, it offers raxibacumab for the treatment and prophylaxis of inhalational anthrax; Anthrasil to treat inhalational anthrax; Botulism Antitoxin Heptavalent for treating botulinum disease; vaccinia immune globulin intravenous that addresses complications from smallpox vaccination; CHIKUNGUNYA, a chikungunya virus-like particle vaccine; and ADENOVIRUS 4/7. Further, the company offers other discovery and preclinical product candidates addressing PHTs, including viral hemorrhagic fevers caused by Ebola, Marburg, Sudan, and Lassa viruses; diarrheal disease caused by Shigella; and heat-labile toxin producing enterotoxigenic Escherichia coli, etc. Additionally, it offers FLU-IGIV to treat Influenza A infection; and ZIKV-IG, a prophylaxis for Zika infections, as well as contract development and manufacturing services to pharma and biotech industries, and government agencies/non-governmental organizations. The company has collaboration agreements with Novavax Inc.; and Johnson & Johnson. Emergent BioSolutions Inc. was founded in 1998 and is headquartered in Gaithersburg, Maryland.
NYSE ended the session with Emergent Biosolutions jumping 10.22% to $16.29 on Monday, following the last session’s upward trend. NYSE dropped 0.21% to $15,840.16, after four sequential sessions in a row of losses, on what was a somewhat negative trend exchanging session today.
Earnings Per Share
As for profitability, Emergent Biosolutions has a trailing twelve months EPS of $0.87.
PE Ratio
Emergent Biosolutions has a trailing twelve months price to earnings ratio of 18.72. Meaning, the purchaser of the share is investing $18.72 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.6%.
Volume
Today’s last reported volume for Emergent Biosolutions is 2325720 which is 136.06% above its average volume of 985227.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is a negative 99.1% and a negative 183.3%, respectively.
Moving Average
Emergent Biosolutions’s worth is way above its 50-day moving average of $12.85 and way below its 200-day moving average of $22.24.
More news about Emergent Biosolutions.
5. Full House Resorts (FLL) – 8.05%
Full House Resorts, Inc. owns, develops, invests in, operates, manages, and leases casinos, and related hospitality and entertainment facilities in the United States. The company owns and operates the Silver Slipper Casino and Hotel in Hancock County, Mississippi, which has 757 slot machines and 24 table games, a surface parking lot, and a 129 hotel rooms; an on-site sportsbook, a fine-dining restaurant, a buffet, and a quick-service restaurant, as well as an oyster bar, a casino bar, and a beachfront bar; and 37-space beachfront RV park. It also owns and operates the Bronco Billy's Casino and Hotel in Cripple Creek, Colorado that has gaming space and 14 hotel rooms, as well as a steakhouse and a casual dining outlet. In addition, the company owns and operates the Rising Star Casino Resort in Rising Sun, Indiana, which has 642 slot machines and 16 table games; a land-based pavilion with approximately 31,500 square feet of meeting and convention space; a contiguous 190-guest-room hotel and an adjacent leased 104-guest-room hotel; a 56-space RV park; surface parking; an 18-hole golf course on approximately 230 acres; and four dining outlets. Further, it owns and operates the Stockman's Casino that is located in Fallon, Nevada, which has 186 slot machines, a bar, a fine-dining restaurant, and a coffee shop; and the Grand Lodge Casino that has 269 slot machines and 9 table games, which is integrated into the Hyatt Regency Lake Tahoe Resort, Spa and Casino in Incline Village, Nevada. Full House Resorts, Inc. was incorporated in 1987 and is headquartered in Las Vegas, Nevada.
NASDAQ ended the session with Full House Resorts rising 8.05% to $10.07 on Monday, after two consecutive sessions in a row of gains. NASDAQ slid 0.58% to $11,787.27, after two successive sessions in a row of losses, on what was a somewhat negative trend trading session today.
PE Ratio
Full House Resorts has a trailing twelve months price to earnings ratio of 2014. Meaning, the purchaser of the share is investing $2014 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -2.6%.
Moving Average
Full House Resorts’s worth is way higher than its 50-day moving average of $8.45 and way higher than its 200-day moving average of $7.06.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Full House Resorts’s stock is considered to be oversold (<=20).
Volatility
Full House Resorts’s last week, last month’s, and last quarter’s current intraday variation average was 0.03%, 0.17%, and 2.24%.
Full House Resorts’s highest amplitude of average volatility was 2.76% (last week), 2.14% (last month), and 2.24% (last quarter).
More news about Full House Resorts.
6. Deere & Company (DE) – 7.53%
Deere & Company manufactures and distributes various equipment worldwide. The company operates through four segments: Production and Precision Agriculture, Small Agriculture and Turf, Construction and Forestry, and Financial Services. The Production and Precision Agriculture segment provides mid-size tractors, combines, cotton pickers and strippers, sugarcane harvesters, harvesting front-end equipment, sugarcane loaders, pull-behind scrapers, and tillage and seeding equipment, as well as application equipment, including sprayers and nutrient management, and soil preparation machinery for grain growers. The Small Agriculture and Turf segment offers utility tractors, and related loaders and attachments; turf and utility equipment, including riding lawn equipment, commercial mowing equipment, golf course equipment, and utility vehicles, as well as implements for mowing, tilling, snow and debris handling, aerating, residential, commercial, golf, and sports turf care applications; other outdoor power products; and hay and forage equipment. This segment also resells products from other manufacturers. It serves dairy and livestock producers, crop producers, and turf and utility customers. The Construction and Forestry segment provides a range of backhoe loaders, crawler dozers and loaders, four-wheel-drive loaders, excavators, motor graders, articulated dump trucks, landscape and skid-steer loaders, milling machines, pavers, compactors, rollers, crushers, screens, asphalt plants, log skidders, log feller bunchers, log loaders and forwarders, log harvesters, and attachments; and roadbuilding equipment. The Financial Services segment finances sales and leases agriculture and turf, and construction and forestry equipment. It also offers wholesale financing to dealers of the foregoing equipment; and extended equipment warranties, as well as finances retail revolving charge accounts. Deere & Company was founded in 1837 and is headquartered in Moline, Illinois.
NYSE ended the session with Deere & Company jumping 7.53% to $433.31 on Monday, after two sequential sessions in a row of gains. NYSE dropped 0.21% to $15,840.16, after four sequential sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.
Earnings Per Share
As for profitability, Deere & Company has a trailing twelve months EPS of $10.93.
PE Ratio
Deere & Company has a trailing twelve months price to earnings ratio of 39.64. Meaning, the purchaser of the share is investing $39.64 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 36.76%.
Yearly Top and Bottom Value
Deere & Company’s stock is valued at $433.31 at 16:32 EST, below its 52-week high of $448.40 and way higher than its 52-week low of $283.81.
Volume
Today’s last reported volume for Deere & Company is 4888740 which is 214.42% above its average volume of 1554810.
More news about Deere & Company.
7. Xenetic Biosciences (XBIO) – 7.28%
Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the discovery, research, and development of biologic drugs and oncology therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. It is also leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, PJSC Pharmsynthez, and SynBio LLC. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.
NASDAQ ended the session with Xenetic Biosciences rising 7.28% to $0.58 on Monday while NASDAQ fell 0.58% to $11,787.27.
Earnings Per Share
As for profitability, Xenetic Biosciences has a trailing twelve months EPS of $-1.704.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -39.85%.
Sales Growth
Xenetic Biosciences’s sales growth for the current quarter is negative 39.9%.
More news about Xenetic Biosciences.
8. Employers Holdings (EIG) – 6.9%
Employers Holdings, Inc., through its subsidiaries, operates in the commercial property and casualty insurance industry primarily in the United States. It offers workers' compensation insurance to small businesses in low to medium hazard industries. The company markets its products through independent local, regional, and national agents and brokers; alternative distribution channels; and national, regional, and local trade groups and associations, as well as directly to customers. Employers Holdings, Inc. was founded in 2000 and is based in Reno, Nevada.
NYSE ended the session with Employers Holdings jumping 6.9% to $45.99 on Monday while NYSE dropped 0.21% to $15,840.16.
Earnings Per Share
As for profitability, Employers Holdings has a trailing twelve months EPS of $1.98.
PE Ratio
Employers Holdings has a trailing twelve months price to earnings ratio of 23.23. Meaning, the purchaser of the share is investing $23.23 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.49%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Feb 27, 2023, the estimated forward annual dividend rate is 1.04 and the estimated forward annual dividend yield is 2.26%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 11%, now sitting on 713.5M for the twelve trailing months.
More news about Employers Holdings.
9. Marathon (MARA) – 6.8%
Marathon Digital Holdings, Inc. operates as a digital asset technology company that mines cryptocurrencies with a focus on the blockchain ecosystem and the generation of digital assets in United States. As of December 31, 2021, it had approximately 8,115 bitcoins, which included the 4,794 bitcoins held in the investment fund. The company was formerly known as Marathon Patent Group, Inc. and changed its name to Marathon Digital Holdings, Inc. in February 2021. Marathon Digital Holdings, Inc. was incorporated in 2010 and is headquartered in Las Vegas, Nevada.
NASDAQ ended the session with Marathon jumping 6.8% to $7.70 on Monday while NASDAQ slid 0.58% to $11,787.27.
Earnings Per Share
As for profitability, Marathon has a trailing twelve months EPS of $-0.13.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -41.77%.
Volatility
Marathon’s last week, last month’s, and last quarter’s current intraday variation average was a positive 7.43%, a negative 0.24%, and a positive 7.57%.
Marathon’s highest amplitude of average volatility was 12.56% (last week), 6.88% (last month), and 7.57% (last quarter).
Volume
Today’s last reported volume for Marathon is 44076900 which is 51.68% above its average volume of 29057600.
Yearly Top and Bottom Value
Marathon’s stock is valued at $7.70 at 16:32 EST, way below its 52-week high of $32.74 and way above its 52-week low of $3.11.
Sales Growth
Marathon’s sales growth is negative 41.6% for the present quarter and 22.2% for the next.
More news about Marathon.
10. Virgin Galactic (SPCE) – 6.52%
Virgin Galactic Holdings, Inc. focuses on the development, manufacture, and operation of spaceships and related technologies for conducting commercial human spaceflight and flying commercial research and development payloads into space. It is also involved in the ground and flight testing, and post-flight maintenance of its spaceflight system vehicles. The company serves private individuals, researchers, and government agencies. Virgin Galactic Holdings, Inc. was founded in 2017 is headquartered in Las Cruces, New Mexico. Virgin Galactic Holdings, Inc. was a former subsidiary of Virgin Orbit Holdings, Inc.
NYSE ended the session with Virgin Galactic rising 6.52% to $6.37 on Monday while NYSE fell 0.21% to $15,840.16.
Earnings Per Share
As for profitability, Virgin Galactic has a trailing twelve months EPS of $-1.55.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -53.97%.
Sales Growth
Virgin Galactic’s sales growth is negative 89.5% for the ongoing quarter and negative 48.1% for the next.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Virgin Galactic’s stock is considered to be oversold (<=20).
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is 12.8% and a drop 12.5% for the next.
More news about Virgin Galactic.
Losers Today
1. XP (XP) – -18.75%
XP Inc. provides financial products and services in Brazil. It offers securities brokerage, private pension plans, commercial, and investment banking products, such as loan operations and transactions in the foreign exchange markets and deposits; product structuring and capital markets services for corporate clients and issuers of fixed income products; advisory services for mass-affluent and institutional clients; and wealth management services for high-net-worth customers and institutional clients. The company also offers Xpeed, an online financial education portal that offers seminars, classes, and learning tools to help teach individuals on topics, such as basics of investing, techniques, and investment strategies, as well as insurance brokerage services. In addition, it operates XP Platform, an open product platform that provides clients to access investment products in the market, including equity and fixed income securities, mutual and hedge funds, private equity, structured products, credit cards, loan operations, life insurance, pension plans, real-estate investment funds, and others. The company was founded in 2001 and is based in São Paulo, Brazil.
NASDAQ ended the session with XP dropping 18.75% to $12.91 on Monday, after four sequential sessions in a row of losses. NASDAQ slid 0.58% to $11,787.27, after two successive sessions in a row of losses, on what was a somewhat bearish trend trading session today.
Earnings Per Share
As for profitability, XP has a trailing twelve months EPS of $0.99.
PE Ratio
XP has a trailing twelve months price to earnings ratio of 13.09. Meaning, the purchaser of the share is investing $13.09 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.58%.
Volatility
XP’s last week, last month’s, and last quarter’s current intraday variation average was a negative 6.05%, a negative 1.51%, and a positive 3.05%.
XP’s highest amplitude of average volatility was 6.74% (last week), 2.82% (last month), and 3.05% (last quarter).
Yearly Top and Bottom Value
XP’s stock is valued at $12.91 at 16:32 EST, below its 52-week low of $13.76.
Volume
Today’s last reported volume for XP is 30058000 which is 645.14% above its average volume of 4033840.
Moving Average
XP’s value is way below its 50-day moving average of $16.18 and way under its 200-day moving average of $19.38.
More news about XP.
2. Dropbox (DBX) – -11.44%
Dropbox, Inc. provides a content collaboration platform worldwide. Its platform allows individuals, families, teams, and organizations to collaborate and sign up for free through its website or app, as well as upgrade to a paid subscription plan for premium features. As of December 31, 2021, the company had approximately 700 million registered users. It serves customers in professional services, technology, media, education, industrial, consumer and retail, and financial services industries. The company was formerly known as Evenflow, Inc. and changed its name to Dropbox, Inc. in October 2009. Dropbox, Inc. was incorporated in 2007 and is headquartered in San Francisco, California.
NASDAQ ended the session with Dropbox dropping 11.44% to $21.22 on Monday, after two sequential sessions in a row of losses. NASDAQ dropped 0.58% to $11,787.27, after two successive sessions in a row of losses, on what was a somewhat down trend exchanging session today.
Earnings Per Share
As for profitability, Dropbox has a trailing twelve months EPS of $-0.62.
Moving Average
Dropbox’s value is under its 50-day moving average of $22.99 and under its 200-day moving average of $22.14.
Volatility
Dropbox’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.10%, a negative 0.40%, and a positive 1.55%.
Dropbox’s highest amplitude of average volatility was 3.79% (last week), 1.98% (last month), and 1.55% (last quarter).
More news about Dropbox.
3. Cross Timbers Royalty Trust (CRT) – -10.01%
Cross Timbers Royalty Trust operates as an express trust in the United States. It holds 90% net profits interests in certain producing and nonproducing royalty and overriding royalty interest properties in Texas, Oklahoma, and New Mexico; and 75% net profits working interest in four properties in Texas and three properties in Oklahoma. Cross Timbers Royalty Trust was founded in 1991 and is based in Dallas, Texas.
NYSE ended the session with Cross Timbers Royalty Trust falling 10.01% to $26.69 on Monday while NYSE slid 0.21% to $15,840.16.
Earnings Per Share
As for profitability, Cross Timbers Royalty Trust has a trailing twelve months EPS of $1.77.
PE Ratio
Cross Timbers Royalty Trust has a trailing twelve months price to earnings ratio of 15.08. Meaning, the purchaser of the share is investing $15.08 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 338.4%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Cross Timbers Royalty Trust’s EBITDA is 30.33.
More news about Cross Timbers Royalty Trust.
4. Albemarle (ALB) – -9.67%
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine segment offers bromine and bromine-based fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines for surfactants, biocides, and disinfectants and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.
NYSE ended the session with Albemarle sliding 9.67% to $258.01 on Monday while NYSE fell 0.21% to $15,840.16.
Earnings Per Share
As for profitability, Albemarle has a trailing twelve months EPS of $3.52.
PE Ratio
Albemarle has a trailing twelve months price to earnings ratio of 73.3. Meaning, the purchaser of the share is investing $73.3 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.88%.
More news about Albemarle.
5. Antero Resources (AR) – -8.39%
Antero Resources Corporation, an independent oil and natural gas company, acquires, explores for, develops, and produces natural gas, natural gas liquids, and oil properties in the United States. As of December 31, 2021, it had approximately 502,000 net acres in the Appalachian Basin; and 174,000 net acres in the Upper Devonian Shale. The company also owned and operated 494 miles of gas gathering pipelines in the Appalachian Basin; and 21 compressor stations. It had estimated proved reserves of 17.7 trillion cubic feet of natural gas equivalent, including 10.2 trillion cubic feet of natural gas; 718 million barrels of assumed recovered ethane; 501 million barrels of primarily propane, isobutane, normal butane, and natural gasoline; and 36 million barrels of oil. The company was formerly known as Antero Resources Appalachian Corporation and changed its name to Antero Resources Corporation in June 2013. Antero Resources Corporation was founded in 2002 and is headquartered in Denver, Colorado.
NYSE ended the session with Antero Resources falling 8.39% to $25.23 on Monday while NYSE fell 0.21% to $15,840.16.
Earnings Per Share
As for profitability, Antero Resources has a trailing twelve months EPS of $-3.43.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 37.74%.
More news about Antero Resources.
6. Qwest Corporation 6.875% Notes due 2054 (CTV) – -8.29%
Innovid Corp. operates as a connected TV advertising delivery and measurement platform. It offers marketer solutions, such as connected TV advertising, Ad serving, creative management, advertising measurement, and identity resolution; publisher solutions; and creative Ad authoring tools. The company serves brands, agencies, and publishers in the Americas, Europe, and the Asia Pacific. Innovid Corp. was founded in 2007 and is headquartered in New York, New York.
NYSE ended the session with Qwest Corporation 6.875% Notes due 2054 falling 8.29% to $1.99 on Monday, following the last session’s downward trend. NYSE fell 0.21% to $15,840.16, after four consecutive sessions in a row of losses, on what was a somewhat negative trend trading session today.
Earnings Per Share
As for profitability, Qwest Corporation 6.875% Notes due 2054 has a trailing twelve months EPS of $-1.31.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -18.71%.
Volume
Today’s last reported volume for Qwest Corporation 6.875% Notes due 2054 is 133020 which is 41.16% below its average volume of 226077.
Revenue Growth
Year-on-year quarterly revenue growth grew by 46.9%, now sitting on 119.39M for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 96.6% and 16.7%, respectively.
Sales Growth
Qwest Corporation 6.875% Notes due 2054’s sales growth is 37.2% for the current quarter and 15.4% for the next.
More news about Qwest Corporation 6.875% Notes due 2054.
7. Comstock Resources (CRK) – -7.94%
Comstock Resources, Inc., an independent energy company, engages in the acquisition, exploration for, development, and production of oil and natural gas primarily in Texas, Louisiana, and North Dakota. As of December 31, 2020, the company had 5.6 trillion cubic feet of natural gas equivalent and 17 million barrels of oil equivalent of proved reserves. It also owns interests in 2,864 producing oil and natural gas wells. Comstock Resources, Inc. was founded in 1983 and is headquartered in Frisco, Texas.
NYSE ended the session with Comstock Resources sliding 7.94% to $12.06 on Monday while NYSE slid 0.21% to $15,840.16.
Earnings Per Share
As for profitability, Comstock Resources has a trailing twelve months EPS of $4.11.
PE Ratio
Comstock Resources has a trailing twelve months price to earnings ratio of 2.93. Meaning, the purchaser of the share is investing $2.93 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 65.83%.
Sales Growth
Comstock Resources’s sales growth is 20.3% for the present quarter and negative 37.1% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 40.7%, now sitting on 3.63B for the twelve trailing months.
More news about Comstock Resources.
8. Sabre Corporation (SABR) – -7.8%
Sabre Corporation, through its subsidiary, Sabre Holdings Corporation, provides software and technology solutions for the travel industry worldwide. It operates in two segments, Travel Solutions and Hospitality Solutions. The Travel Solutions segment operates as a business-to-business travel marketplace that offers travel content, such as inventory, prices, and availability from a range of travel suppliers, including airlines, hotels, car rental brands, rail carriers, cruise lines, and tour operators with a network of travel buyers comprising online and offline travel agencies, travel management companies, and corporate travel departments. This segment also provides a portfolio of software technology products and solutions through software-as-a-service (SaaS) and hosted delivery models to airlines and other travel suppliers. Its products include reservation systems for carriers, commercial and operations products, agency solutions, and data-driven intelligence solutions. The Hospitality Solutions segment provides software and solutions to hoteliers through SaaS and hosted delivery models. Sabre Corporation was incorporated in 2006 and is headquartered in Southlake, Texas.
NASDAQ ended the session with Sabre Corporation falling 7.8% to $5.32 on Monday while NASDAQ dropped 0.58% to $11,787.27.
Earnings Per Share
As for profitability, Sabre Corporation has a trailing twelve months EPS of $-4.42.
Revenue Growth
Year-on-year quarterly revenue growth grew by 50.4%, now sitting on 2.41B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Sabre Corporation’s stock is considered to be overbought (>=80).
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 36.2% and 58.6%, respectively.
Volatility
Sabre Corporation’s last week, last month’s, and last quarter’s current intraday variation average was a negative 7.52%, a negative 1.57%, and a positive 3.25%.
Sabre Corporation’s highest amplitude of average volatility was 9.50% (last week), 3.79% (last month), and 3.25% (last quarter).
More news about Sabre Corporation.
9. SmileDirectClub (SDC) – -7.19%
SmileDirectClub, Inc., an oral care company, offers clear aligner therapy treatment. The company manages the end-to-end process, which include marketing, aligner manufacturing, fulfillment, treatment by a doctor, and monitoring through completion of their treatment with a network of approximately 250 licensed orthodontists and general dentists through its teledentistry platform, SmileCheck in the United States, Puerto Rico, Canada, Australia, the United Kingdom, New Zealand, Ireland, Hong Kong, Germany, Singapore, France, Spain, and Austria. It also offers aligners, impression and whitening kits, whitening gels, and retainers; and toothbrushes, toothpastes, water flossers, SmileSpa, and various ancillary oral care products. The company was founded in 2014 and is headquartered in Nashville, Tennessee.
NASDAQ ended the session with SmileDirectClub dropping 7.19% to $0.59 on Monday, after four sequential sessions in a row of losses. NASDAQ dropped 0.58% to $11,787.27, after two sequential sessions in a row of losses, on what was a somewhat down trend exchanging session today.
Earnings Per Share
As for profitability, SmileDirectClub has a trailing twelve months EPS of $-2.334.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 8.7% and 12%, respectively.
Volume
Today’s last reported volume for SmileDirectClub is 926419 which is 66.68% below its average volume of 2781120.
Sales Growth
SmileDirectClub’s sales growth is negative 28.2% for the ongoing quarter and negative 22.1% for the next.
Yearly Top and Bottom Value
SmileDirectClub’s stock is valued at $0.59 at 16:32 EST, way below its 52-week high of $3.10 and way higher than its 52-week low of $0.32.
More news about SmileDirectClub.
10. Vaalco Energy (EGY) – -6.79%
VAALCO Energy, Inc., an independent energy company, acquires, explores for, develops, and produces crude oil and natural gas. The company holds Etame production sharing contract related to the Etame Marin block located offshore in the Republic of Gabon, West Africa. It also owns interests in an undeveloped block offshore Equatorial Guinea, West Africa. VAALCO Energy, Inc. was founded in 1985 and is headquartered in Houston, Texas.
NYSE ended the session with Vaalco Energy falling 6.79% to $4.39 on Monday, after two successive sessions in a row of losses. NYSE fell 0.21% to $15,840.16, after four consecutive sessions in a row of losses, on what was a somewhat bearish trend trading session today.
Earnings Per Share
As for profitability, Vaalco Energy has a trailing twelve months EPS of $1.14.
PE Ratio
Vaalco Energy has a trailing twelve months price to earnings ratio of 3.85. Meaning, the purchaser of the share is investing $3.85 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 48.42%.
Volume
Today’s last reported volume for Vaalco Energy is 2218960 which is 30.69% above its average volume of 1697800.
More news about Vaalco Energy.
Stay up to date with our winners and losers daily report
